alchemy wellness semaglutide Wellness, Dallas What is the Semaglutide Weight

The authors checked a subset of 909 participants against their medical records and found that participants tended to overstate their weight loss (5.79% measured vs 11.8% self-reported, median BMI change)

This means that the combination of semaglutide and Zofran might lead to better results for individuals who would otherwise stop using semaglutide because of nausea

Funding and Disclosures The research received funding from multiple sources

[DOI] [PMC free article] [PubMed] [Google Scholar] 228

In 2021, semaglutides weight-loss brand Wegovy (weekly injectable) was approved for obesity, followed by tirzepatide (Mounjaro) for diabetes (2022) and Zepbound (tirzepatide for obesity) in late 2023